Instylla
PrivateLast Round
Early Stage
VC
Jul 28, 2026
Est. Valuation
$125.43M
Total Funding Raised
$81.96M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Instylla is a medical device company that develops liquid embolic solutions for interventional radiology, aimed at providing controlled and effective embolization to enhance patient outcomes.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Instylla Comparables
Compare Instylla with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Fluidx Medical Technology | 84% | |
| ABK Biomedical | 81% | |
| Cortex, Inc. | 79% |
Instylla Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Jul 28, 2026 | ||||
| Series C | Aug 1, 2023 | ||||
| Series B | Oct 13, 2020 | ||||
| Debt | Apr 28, 2020 | ||||
| Series A Extension | Jun 12, 2018 | ||||
Series A | Jun 6, 2017 |
Instylla Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Incept LLC | Series C, Series A, Series B |
| Ascension Ventures | Series C, Series A, Series B |
| CHV | Series C, Series B |
| Incept AI | Series C, Series B |
| Sparta Group LLC | Series C, Series B |
| Catalyst Health Ventures | Series C, Series A, Series B |
| Excelestar Ventures | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 36% MoM, reaching 3.5K.
- Jul 28, 2026
$35M raised in early stage VC round.
Instylla Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Instylla's valuation, stock price, and market status.
Is Instylla a public or private company?
Instylla is a private company.
What is the current stock price of Instylla?
Instylla is a private company with no public stock price. No recent secondary market data is available.
How much is Instylla worth (valuation)?
Instylla's valuation is estimated at $125.4M based on funding round data.
Can I buy Instylla stock?
Instylla shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Instylla's last funding round?
Instylla's most recent funding round was Series B Extension on August 15, 2023.
Who are the main investors in Instylla?
Key investors in Instylla include CHV, Catalyst Health Ventures, Excelestar Ventures, Delos Capital Partners.
Will Instylla IPO soon?
No public IPO plans have been announced for Instylla.
How can I track Instylla secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Instylla's secondary market activity and sign up for updates.